Comparative urinary metabolomics reveals unique and shared pathways in COVID-19 and liver diseases
Key Points
This research aims to explore metabolic changes in COVID-19 and liver diseases to identify unique and common pathways.
Conducted a comparative urinary metabolomics analysis
Examined metabolic profiles of COVID-19 and liver disease samples
Identified specific metabolic pathways involved
Revealed unique metabolic pathways in COVID-19
Showed shared metabolic alterations between COVID-19 and liver diseases
Identified potential biomarkers for diagnosis and treatment targeting
Abstract
These findings enhance our understanding of disease-specific metabolic remodelling and point to potential biomarkers for diagnosis and therapeutic targeting.
Like
Bookmark
Share
View Full Paper
Like
Bookmark
Share
View Full Paper
Comparative urinary metabolomics reveals unique and shared pathways in COVID-19 and liver diseases | Synapse